Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients
Surgery (partial or radical nephrectomy) is the standard of care [...]
Surgery (partial or radical nephrectomy) is the standard of care [...]
This year’s American Society of Clinical Oncology Genitourinary Cancers (ASCO [...]
Adjuvant therapy aims to reduce the risk of the cancer [...]
In this randomised phase 3 trial, the effectiveness and safety [...]
A recent phase 3 study called CheckMate 914 has shown [...]
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
Yesterday is was announced that the Scottish Medicines Consortium (SMC) [...]
Late last week we learnt that the National Institute for [...]
The results from the IMmotion010 study were presented at the [...]